Articles tagged with Cancer Patients
A recent study published in Mayo Clinic Proceedings found that robotic surgery offers a less invasive alternative to traditional treatments for oropharyngeal cancer, resulting in high survival rates and improved patient quality of life. The treatment preserved patients' ability to swallow and maintained excellent speech performance.
A combination therapy of dendritic cell implants and radiotherapy was found to be effective in inducing tumor-specific immune responses in 52.9% of trial patients with high-risk soft tissue sarcomas. The treatment resulted in dramatic increases in immune T cells in the tumors, leading to significant clinical benefits.
The new drug Vemurafenib doubles the median survival time of metastatic melanoma patients with a specific genetic mutation, from 6 months to 15.9 months. In responding patients, the drug stops cancer progression for an additional 6.7 months.
Researchers found that palliative care staff use multifaceted approaches to provide physical, psychological, social, spiritual, and existential care. These caregiving activities can improve the quality of death for both patients and their families.
Researchers have found that combining gemcitabine with nab-paclitaxel increases intratumoral gemcitabine levels by reducing the primary metabolizing enzyme, cytidine deaminase. This combination may lead to improved patient outcomes and better administration of therapeutic treatments.
Research at Yale University reveals that prostate cancer treatment is often not necessary for older men with short life expectancy. The study found that cancer treatment became more common among men with moderate-risk tumors and shorter life expectancies, despite being unlikely to benefit from it.
A study published in the Journal of Clinical Oncology found that women who underwent chemotherapy with the CMF regimen between 1976 and 1995 scored slightly lower on cognitive tests compared to those without a history of cancer. The differences were subtle but statistically significant, affecting word learning, memory, and information ...
A new study found that patients with chronic myeloid leukemia (CML) who have not responded to interferon treatments experience significant long-term benefits when switching to imatinib. Up to 93% of patients survive at least eight years, compared to only three to six years prior to imatinib.
A new study published in Radiology found that computed tomography (CT) colonography, also known as virtual colonoscopy, is an effective screening tool for colorectal cancer in adults over 65. The study analyzed data from 477 patients over 65 and found high diagnostic accuracy rates comparable to those for younger patients.
A survey of over 41,000 patients with various cancers found that women, young people, and ethnic minorities experience delayed recognition due to symptom characteristics. GPs are less likely to consider cancer in younger patients and those from different ethnic groups, leading to longer consultation times.
A new study has found that cancer patients with breast, melanoma, testicular, and endometrial cancers are more likely to be referred to a specialist after just one or two consultations. In contrast, patients with less common cancers such as multiple myeloma, pancreatic, stomach, and ovarian cancer require three or more visits before re...
A recent analysis of data from the National CT Colonography Trial confirms the efficacy of CT colonography as a front-line colorectal cancer screening tool for seniors. The study found that CT colonography accurately detects polyps and precancerous lesions in people aged 65 and older, comparable to standard colonoscopy.
Researchers evaluated a teaching program for breaking bad news to patients, finding that medical students reported improved comfort in addressing difficult topics. The program involved videotaped sessions with standardized patients and post-interview discussions, which were found to be highly beneficial.
Researchers say anti-clotting effect of heparin is well established but its impact on cancer patients remains unclear. The SAVE-ONCO study found semuloparin reduced thromboembolism incidence but had no significant effect on major bleeding and death.
Researchers found a powerful cause-and-effect relationship between elevated platelets and ovarian cancer progression. Tumors stimulate platelet production, which strengthens the disease, reducing survival rates in patients with thrombocytosis.
Malnourished cancer patients who received oral nutritional support showed improvements in aspects of quality of life, including emotional functioning and loss of appetite. However, the interventions had no impact on mortality rates or consistent effects on weight gain.
A study found that injectable Low Molecular Weight Heparin (LMWH) treatment increased clot prevention rates compared to warfarin-based therapy in advanced cancer patients. Despite being recommended by guidelines, LMWH use is low due to patient preference for oral warfarin.
Researchers found that certain drugs can activate hepatitis B viruses in liver cells, increasing viral replication. This activation is linked to the stress protein p38, which can lead to complications in transplant patients.
A study published in PLOS ONE found that fetal exposure to radiation increases the risk of developing testicular cancer in male mice. The research suggests that DNA-damaging agents, such as radiation, may be responsible for the increasing incidence of testicular cancer in young Caucasian men.
A new study published in CANCER found that many older lung cancer patients receive radiation therapy without extending their lifespan. Researchers analyzed data from the Surveillance, Epidemiology and End Results (SEER)-Medicare registry to determine if additional radiation therapy after surgery improves survival rates.
Researchers analyzed tumor specimens from 19 advanced stage carcinoma patients, discovering changes in biomarker expression that may impact therapy selection for women with recurrent ovarian cancer. The study highlights the importance of analyzing current tumor tissue to make informed treatment decisions.
A new clinical trial demonstrates the effectiveness of adaptive radiotherapy in treating head and neck cancer, requiring only one or two replans to maintain treatment quality. The study found that ART keeps radiation tightly fitted to a patient's body, offering individualized treatment with minimal burden.
A study by Concordia University and McGill University Health Centre found a strong link between muscle mass and strength in cancer patients with severe fatigue. The researchers suggest that specialized strength training programs could improve muscle mass and reduce fatigue, enhancing the quality of life for these patients.
The Australian Cancer Research Foundation has committed $2 million to two new cancer research laboratories at the Walter and Eliza Hall Institute. The new facilities will enable researchers to study the biology of epithelial cancers and develop new treatments for breast, ovarian, lung, and leukemia patients.
Researchers have developed a new approach to detect cancer cells in the bloodstream, allowing for real-time assessment and control of disease spread. The method could help predict response and resistance to therapies, enabling more effective treatment decisions.
A study published in Cancer Prevention Research found that soy isoflavone supplements did not decrease breast cancer cell proliferation. The results are consistent with previous studies on the effectiveness of dietary supplements in preventing cancer.
Different subgroups of non-small cell lung cancer exhibit distinct patterns of spread in the body, suggesting fundamentally different diseases. Targeted therapies have shown dramatic clinical responses in patients with ALK positive NSCLC, offering new hope for treatment.
Researchers developed a highly sensitive blood test for detecting and analyzing circulating tumor cells (CTCs) in cancer patients. The 'biopsy in a blood test' provides information comparable to surgical biopsies, enabling better monitoring, prediction, and understanding of cancer progression.
A new study published in Gastroenterology reveals that Barrett's esophagus patients who smoke are twice as likely to develop esophageal cancer. Tobacco smoking emerged as the strongest lifestyle risk factor for cancer progression in this patient group.
Researchers analyzed past studies on cancer-related pain reduction and found that psychosocial interventions can significantly improve cancer patients' pain severity. Skill-based interventions and educational approaches were most successful in reducing pain and its impact on daily life.
Smoking doubles the risk of developing oesophageal cancer in people with Barrett's Oesophagus. A 13-year study involving over 3000 patients found those who smoked tobacco were twice as likely to develop cancer.
Research team led by Edward T. H. Yeh discovers that SENP1 regulates SUMOylation of STAT5, essential for lymphoid development of T and B cells. Without SENP1, STAT5 cannot be activated or recycled, leading to severe defects in immune cell development.
A new study found that transplant patients with head and neck cancer are more likely to be non-smokers and non-drinkers, and less likely to survive past one year of diagnosis. The risk for developing head and neck cancer is small, but the study highlights the need for regular screenings and aggressive treatment.
A study by UC Davis researchers found that newer radiation therapy technology, intensity-modulated radiation therapy (IMRT), improves patients' quality of life for those with advanced head and neck cancers. IMRT was associated with fewer long-term side effects, leading to better quality of life.
A Danish health care fast track program has reduced the waiting time between a patient's initial meeting with a healthcare provider and their first treatment for head and neck cancer from 69 days in 2002 to 41 days in 2010. The program, implemented in 2008, prioritized cancer patients and implemented various reforms to curb wait times.
Researchers at Georgetown Lombardi Comprehensive Cancer Center are studying whether high-risk HPV-positive patients with head and neck cancer should receive more or less chemotherapy. Their research suggests intensifying therapy could increase cure rates, but additional studies are needed.
A 1993 Chevrolet Corvette 40th Anniversary coupe was sold at the Barrett-Jackson Scottsdale Auction, raising $120,000 for cancer research at TGen. The funds support research into colon and prostate cancer in memory of Russ and Brian Jackson.
Researchers have identified a new pathway that targets the root cause of glioblastoma resistance, paving the way for more effective treatments. By understanding how this complex signaling process works, scientists hope to develop novel therapies to improve patient outcomes and extend survival rates.
A new study found that many cancer patients continue to smoke after diagnosis, with 39% of lung cancer and 14% of colorectal cancer patients smoking at diagnosis. Factors such as insurance, emotional support, and education level can predict continued smoking in these patients.
Researchers found that prostaglandin E2 accelerates colorectal cancer development by silencing tumor-suppressing genes and increasing DNA methylation. Combining anti-inflammatory and demethylating agents reduced tumors by up to 93% in mice with colorectal cancer.
Researchers at IMIM have discovered a new mechanism of resistance to colon cancer treatment, where a mutation in the EGFR oncogene causes resistance to drug cetuximab. The finding has significant clinical implications and opens up possibilities for using alternative treatments like panitumumab.
A recent study found that adding oxaliplatin to adjuvant chemotherapy for stage III colon cancer patients in the general population improved overall survival rates. The research also showed that this combination therapy was effective across various practice settings, including older and minority patients with comorbid conditions.
A study by Virginia Commonwealth University found that patients receive only 46% of guideline-recommended preventive services during routine annual visits. The most common services delivered were screenings for colorectal cancer, hypertension, and breast cancer.
Scientists have documented how ALK positive advanced non-small cell lung cancer becomes resistant to crizotinib, a previously effective treatment. Researchers now aim to develop combination therapies to tackle this resistance and improve patient outcomes.
Researchers have identified a novel connection between two RNA-binding proteins, Musashi1 and HuR, which plays a significant role in glioblastoma development. The study suggests that disruptions to these regulatory processes can contribute to tumor formation.
Researchers at Stanford University have used a computer algorithm to find markers that predict how deadly bladder cancer will be, offering faster and more accurate analysis of cancer risk. The test can be performed by someone with little training and may help identify patients with the most aggressive subtype before it becomes invasive.
A leading cancer researcher highlights high levels of doctor-patient trust and confidence within the NHS. Closer clinical relationships between physicians and patients are crucial for coping with treatment and diagnosis. However, cost-cutting measures risk eroding this trust if not carefully implemented.
Researchers found that patients with 'matted' lymph nodes had a 69% survival rate over three years, compared to 94% for those without matted nodes. The study's results may help doctors identify patients at higher risk and reduce standard treatment side effects.
Researchers reassessed symptom indices to detect ovarian cancer early on, finding similar results to previous reports and a limited benefit in advancing diagnosis. The study highlights the challenges of detecting ovarian cancer early due to its biology, screening limitations, and clinical characteristics.
Dr. Sandra Van Schaeybroeck's research aims to identify ways to increase survival from bowel cancer by developing new treatment strategies and understanding drug resistance. The £688,000 Cancer Research UK Clinical Scientist Fellowship renewal will support her work for another three years.
In a preclinical study, ganetespib slowed the growth of cancer cells from non-small cell lung tumors with a KRAS gene mutation. The drug was more active when combined with traditional lung cancer treatments and other targeted therapies, indicating its potential effectiveness in treating patients with KRAS-mutant NSCLC.
TGen researchers identify multiple novel mutations and pathway changes in never-smoker lung cancer patients, diverging from those found in smokers. These findings hold promise for developing therapeutic targets in this patient population.
A preclinical study found that a combination of estrogen-targeting drugs significantly reduced tobacco carcinogen-induced lung tumors in mice. The treatment, which blocks estrogen production and its effects on the body, showed maximum antitumor effects in both healthy and precancerous cells.
Researchers identified potential gene mutations and pathway alterations that could lead to lung cancer in never-smokers. They found that these patients' tumors lacked common genes associated with lung cancer, making them ideal cases for discovering new mutations that may drive the disease.
Researchers developed a sensitive test to analyze circulating tumor cells in blood, enabling clinicians to track cancer progress and treatments. The method uses high-throughput mass spectrometry analysis, allowing for the detection of genetic mutations present in small numbers of malignant cells.
Most patients who survive oesophageal cancer surgery recover an average quality of life, but one in six experience significant deterioration. Hospitals must improve identification and follow-up for these patients to prevent persistently low quality of life.
A new downloadable tool from the University of Colorado Cancer Center guides cancer survivors through a personalized exercise plan, helping them set goals and track progress. The program aims to overcome common challenges faced by cancer patients, including fatigue and self-doubt.
Women with breast cancer who take anti-estrogen supplements may be decreasing their risk for melanoma. Risk for melanoma was 60 percent higher among patients who did not receive anti-estrogen therapy compared to those who received it.
Researchers discovered an agent, PEDF, that suppresses brain metastatic activity and shields the brain from tumor-induced damage. This finding represents a significant step forward in managing brain metastases, a major challenge in cancer treatment.
Researchers have discovered a technique to keep normal cells and tumor cells taken from an individual cancer patient alive in the laboratory. This breakthrough could revolutionize personalized cancer medicine and regenerative medicine, enabling oncologists to find the right therapies for patients.